https://www.businesswire.com/news/home/20200528005477/en/SAB-Biotherapeutics-Confirms-Neutralizing-Antibodies-SARS-CoV-2-Begins
0
0
SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel COVID-19 Therapeutic Candidate
+ 56 more
5/28/20 at 12:20pm
Organization
Business Wire
Authors
Details
45 words
Summarize
SIOUX FALLS, S.D.--(BUSINESS WIRE)-- #COVID19--SAB Biotherapeutics announces neutralizing antibody data for novel COVID-19 therapeutic candidate with clinical production underway and on-track.
Create an account or login to join the discussion